Company profile for ProfoundBio

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Aiming to help patients with cancer through the discovery and development of novel targeted therapeutics with curative potential. We are focused on discovering and advancing novel classes of therapeutics that are designed to leverage the immune system to eradicate cancer. For patients whose immune systems are insufficient to mount an anti-cancer response, we also develop therapeutics that delivery a small molecule payload spe...
Aiming to help patients with cancer through the discovery and development of novel targeted therapeutics with curative potential. We are focused on discovering and advancing novel classes of therapeutics that are designed to leverage the immune system to eradicate cancer. For patients whose immune systems are insufficient to mount an anti-cancer response, we also develop therapeutics that delivery a small molecule payload specifically to tumor cells. Our team of experienced scientists take a fresh look at how to best eradicate cancer by taking an open, creativity approach to drug discovery.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
China
Address
Address
Suite 419, Building A4, 218 Xinghu Street, Suzhou Industrial Park, China 21512...
Telephone
Telephone
+86-512-6799-1868
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/genmab-sheds-another-clinical-adc-18b-profoundbio-buy

FIERCE BIOTECH
17 Nov 2025

https://www.fiercebiotech.com/biotech/genmab-discards-clinical-adc-picked-last-years-18b-profoundbio-buy

FIERCE BIOTECH
17 Sep 2025

https://www.globenewswire.com/news-release/2024/08/08/2927105/0/en/Genmab-Announces-Financial-Results-for-the-First-Half-of-2024.html

GLOBENEWSWIRE
08 Aug 2024
Genmab buys ProfoundBio for $1.8B
Genmab buys ProfoundBio for $1.8B

04 Jun 2024

// PRESS RELEASE

https://www.chemexpress.com/newsletter/Exatecans

PRESS RELEASE
04 Jun 2024

https://www.globenewswire.com/news-release/2024/05/21/2885823/0/en/Genmab-Completes-Acquisition-of-ProfoundBio.html

GLOBENEWSWIRE
21 May 2024

https://ml-eu.globenewswire.com/Resource/Download/c4442fee-72fd-4922-b334-504a4ab313aa

GLOBENEWSWIRE
04 Apr 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty